Creative Medical Technology Holdings, Inc. (CELZ)
USD 2.0
(0.5%)
USD 2.0
(0.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -8.02 Million | -7.79 Million | -2.21 Million | -434.55 Thousand | -1.21 Million | -1.05 Million |
| Net Income | -5.28 Million | -10.14 Million | 19.21 Million | -36.32 Million | -8.48 Million | -13.65 Million |
| Depreciation & Amortization | 94.58 Thousand | 92.08 Thousand | 92.08 Thousand | 66.79 Thousand | 26.95 Thousand | 21.14 Thousand |
| Deferred income taxes | 2.94 Million | 2.25 Million | -26.52 Million | 33.98 Million | - | 11.19 Million |
| Stock-based compensation | 36.64 Thousand | 68.74 Thousand | 595.38 Thousand | 170.32 Thousand | - | 1877.00 |
| Change in working capital | -2.83 Million | 2.18 Million | 249.46 Thousand | 692.79 Thousand | 62.2 Thousand | 129.42 Thousand |
| Other non-cash items | -2.98 Million | -2.25 Million | 4.15 Million | 979.96 Thousand | 7.18 Million | 1.25 Million |
| Investing Cash Flow | 3.44 Million | -10.07 Million | - | -250 Thousand | - | - |
| Investments in PPE | -100 Thousand | - | - | -250 Thousand | - | - |
| Acquisitions | -26.3 Million | - | - | - | - | - |
| Investment purchases | -22.85 Million | -10.07 Million | - | - | - | - |
| Sales/Maturities of investments | 26.4 Million | - | - | - | - | - |
| Other Investing Activities | 26.3 Million | -10.07 Million | - | -250 Thousand | - | - |
| Financing Cash Flow | -270.95 Thousand | 15.47 Million | 12.84 Million | 693.92 Thousand | 997.68 Thousand | 1.34 Million |
| Debt repayment | - | - | -5.95 Million | -17 Thousand | -355.11 Thousand | -462.29 Thousand |
| Dividends payments | - | - | -27.72 Thousand | - | - | - |
| Common Stock Repurchased | -270.95 Thousand | - | -196.75 Thousand | - | - | - |
| Common Stock Issuance | - | 15.47 Million | 14.75 Million | - | - | - |
| Other Financing Activities | - | 457.00 | 9.02 Million | 710.92 Thousand | 1.35 Million | 1.8 Million |
| Accounts receivables | - | 2485.00 | -2485.00 | 5600.00 | 4000.00 | -4799.00 |
| Accounts payables | -2.95 Million | 2.5 Million | 410.96 Thousand | 30.11 Thousand | -11.05 Thousand | 94.76 Thousand |
| Inventory | 3600.00 | 672.00 | -10.86 Thousand | - | - | 4.19 Million |
| Other working capital | 108.2 Thousand | -322.58 Thousand | -148.14 Thousand | 657.08 Thousand | 69.25 Thousand | -4.15 Million |
| Cash at beginning of period | 8.32 Million | 10.72 Million | 98.01 Thousand | 88.64 Thousand | 304.05 Thousand | 13.69 Thousand |
| Cash at end of period | 3.46 Million | 8.32 Million | 10.72 Million | 98.01 Thousand | 88.64 Thousand | 304.05 Thousand |
| Capital Expenditure | -100 Thousand | - | - | -250 Thousand | - | - |
| Effect of forex changes on cash | -1.00 | - | - | - | - | - |
| Net cash flow / Change in cash | -4.85 Million | -2.4 Million | 10.62 Million | 9364.00 | -215.4 Thousand | 290.35 Thousand |
| Free Cash Flow | -8.12 Million | -7.79 Million | -2.21 Million | -684.55 Thousand | -1.21 Million | -1.05 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.55 Million | -1.04 Million | -1.67 Million | -5.28 Million | -1.45 Million | -1.1 Million |
| Depreciation & Amortization | 29.27 Thousand | 29.27 Thousand | 25.52 Thousand | 94.58 Thousand | 23.02 Thousand | 23.02 Thousand |
| Deferred income taxes | - | - | -108.76 Thousand | 2.94 Million | -30.17 Thousand | -64.21 Thousand |
| Stock-based compensation | 9162.00 | 9162.00 | 9162.00 | 36.64 Thousand | 9162.00 | 9162.00 |
| Change in working capital | 49.99 Thousand | 106.24 Thousand | -217 Thousand | -2.83 Million | 117.24 Thousand | 83.2 Thousand |
| Other non-cash items | 82.39 Thousand | 48.13 Thousand | 74.68 Thousand | -2.98 Million | 30.17 Thousand | 64.21 Thousand |
| Investing Cash Flow | - | 6.52 Million | 1.12 Million | 3.44 Million | 1.82 Million | -4.53 Million |
| Investments in PPE | 4.00 | - | -100 Thousand | -100 Thousand | - | - |
| Acquisitions | - | - | -1.00 | -26.3 Million | - | - |
| Investment purchases | - | - | -22.85 Million | -22.85 Million | -2.07 Million | - |
| Sales/Maturities of investments | - | 6.52 Million | 26.4 Million | 26.4 Million | 4 Million | 11.13 Thousand |
| Other Investing Activities | - | 6.52 Million | -2.31 Million | 26.3 Million | -100 Thousand | -4.55 Million |
| Financing Cash Flow | -66.61 Thousand | -82.79 Thousand | -270.95 Thousand | -270.95 Thousand | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -66.71 Thousand | -82.79 Thousand | -270.95 Thousand | -270.95 Thousand | - | - |
| Common Stock Issuance | 100.00 | - | - | - | - | - |
| Other Financing Activities | 100.00 | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -14.68 Thousand | 19.56 Thousand | -49.76 Thousand | -2.95 Million | 22.63 Thousand | -9009.00 |
| Inventory | 3200.00 | - | 1200.00 | 3600.00 | 2400.00 | - |
| Other working capital | 61.47 Thousand | 86.68 Thousand | -168.44 Thousand | 108.2 Thousand | 92.21 Thousand | 92.21 Thousand |
| Cash at beginning of period | 9 Million | 3.46 Million | 4.5 Million | 8.32 Million | 3.98 Million | 9.51 Million |
| Cash at end of period | 7.47 Million | 9 Million | 3.46 Million | 3.46 Million | 4.5 Million | 3.98 Million |
| Capital Expenditure | 4.00 | - | -100 Thousand | -100 Thousand | - | - |
| Effect of forex changes on cash | - | - | - | -1.00 | - | - |
| Net cash flow / Change in cash | -1.53 Million | 5.54 Million | -1.04 Million | -4.85 Million | 517.55 Thousand | -5.52 Million |
| Free Cash Flow | -1.46 Million | -896.86 Thousand | -1.99 Million | -8.12 Million | -1.3 Million | -986.73 Thousand |
0QMR
AMGO
3700
600526
PARACABLES
SSRM